Industry Digs Into Specifics Of CMS Proposal For Covering Clinical Trial Costs

Device industry representatives say CMS' latest proposed revision of its policy for covering certain clinical trial costs is a significant improvement over the previous proposal, but claim some specific requirements would be too burdensome on manufacturers